Terminated PHASE4 INTERVENTIONAL 2-arm NCT00800137

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISECONTROL)

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL)

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Hematoma

Interventions Warfarin or coumadin low molecular weight heparin or unfractionated heparin

Updated 7 times since 2017 Last updated: Aug 13, 2018 Started: Dec 31, 2008 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

At time of pre-specified 2nd interim analysis

Other terminated trials from Canadian Institutes of Health Research (CIHR)

See all terminations from Canadian Institutes of Health Research (CIHR)

Other Hematoma trials with similar outcome

NCT05292326 · Phase NA · Mar 2025

Browse all Hematoma trials

A PHASE4 clinical study on Hematoma, this trial is terminated or withdrawn. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE4
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Sep 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Sep 2018 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
Ottawa Heart Institute Research Corporation

Data source: Ottawa Heart Institute Research Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Calgary, Canada , Edmonton, Canada , Halifax, Canada , Hamilton, Canada , Kingston, Canada , Kitchener, Canada , Laval, Canada , London, Canada , Montreal, Canada , Newmarket, Canada and 9 more locations